NEW ZEALAND MEDICAL JOURNAL最新文献_第8页

The New Zealand Ministry of Health indicators for inpatient stroke care: results from an Auckland hospital. 新西兰卫生部住院中风护理指标：奥克兰一家医院的结果。

IF 1.2

NEW ZEALAND MEDICAL JOURNAL Pub Date : 2024-11-29 DOI: 10.26635/6965.6562

Zofia E Karasinska-Stanley, Kalpa Jayanatha, Edward Wong, Arindam Kar

{"title":"The New Zealand Ministry of Health indicators for inpatient stroke care: results from an Auckland hospital.","authors":"Zofia E Karasinska-Stanley, Kalpa Jayanatha, Edward Wong, Arindam Kar","doi":"10.26635/6965.6562","DOIUrl":"10.26635/6965.6562","url":null,"abstract":"Aim: New Zealand's Ministry of Health sets three quality metrics for inpatient stroke care: admission to an organised stroke unit within 24 hours (target 80%), appropriate use of reperfusion therapy (target 12% for ischemic stroke) and transfer to rehabilitation services within 7 days (target 80%). Our aim was to evaluate a large Auckland tertiary hospital's performance against these indicators.Methods: A retrospective study of 200 consecutive stroke patients admitted between April 4 and August 1, 2021, was conducted.Results: Fifty percent (100/200) of patients were admitted to the stroke unit within 24 hours. Sixteen point six percent (27/183) of ischaemic stroke patients received reperfusion therapy. Twenty-four point five percent (49/200) were transferred to rehabilitation services, of which 40.8% (20/49) were within 7 days of presentation. Patients were less likely to be admitted to the stroke unit within 24 hours if not admitted by the stroke service, if admitted out-of-hours or if suffering an inpatient stroke. Timely admission to the stroke unit was associated with receipt of reperfusion therapy, shorter time to inpatient rehabilitation transfer and shorter duration of admission. Patients with inpatient stroke were less likely to be discharged in a timely manner (adjusted hazard ratio [HR] 0.19; 95% CI 0.07-0.50). All-cause mortality during a hospitalisation episode with a stroke diagnosis was likely to occur early in the admission (adjusted HR 1.82; 95% CI 1.01-3.32).Conclusions: The hospital met the reperfusion therapy target but fell short on timely stroke unit admission and rehabilitation transfer. An after-hours effect on stroke unit admission was observed, previously undocumented in New Zealand.","PeriodicalId":48086,"journal":{"name":"NEW ZEALAND MEDICAL JOURNAL","volume":"137 1606","pages":"63-72"},"PeriodicalIF":1.2,"publicationDate":"2024-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142752037","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Addressing data needs crucial for improving infant, child and youth mental health and substance-related harms in Aotearoa New Zealand: key design and ethical considerations for future research. 解决数据需求对于改善新西兰奥特罗阿的婴儿、儿童和青少年心理健康和药物相关危害至关重要：未来研究的关键设计和伦理考虑。

IF 1.2

NEW ZEALAND MEDICAL JOURNAL Pub Date : 2024-11-29 DOI: 10.26635/6965.6702

Lovely Dizon, Vartika Sharma, Terryann C Clark, Jude Ball, Terry Fleming, Karin Isherwood, Helen Lockett

{"title":"Addressing data needs crucial for improving infant, child and youth mental health and substance-related harms in Aotearoa New Zealand: key design and ethical considerations for future research.","authors":"Lovely Dizon, Vartika Sharma, Terryann C Clark, Jude Ball, Terry Fleming, Karin Isherwood, Helen Lockett","doi":"10.26635/6965.6702","DOIUrl":"10.26635/6965.6702","url":null,"abstract":"Aim: To evaluate the available data on mental health and substance-related harm among infants, children and young people (ICY) in Aotearoa New Zealand.Methods: A scoping review was undertaken to take stock of current data and identify gaps.Results: Although there are quality studies, there is a lack of comprehensive, contemporary population-based data to monitor the prevalence and magnitude of mental health conditions and substance use-related harm for children and young people. Existing data are inconsistently measured and are not centrally located or available for all age groups, particularly infants and children. Whānau/family units are seldom considered or prioritised.Conclusions: Aotearoa New Zealand lacks accurate, up-to-date, comprehensive ICY mental health and substance use data to inform investment, service delivery and evidence-based policy. We advocate for enhanced surveillance and monitoring through population-based mental health and addiction studies with Indigenous and other locally designed measures, and propose key design and ethical considerations for future research. Future research must prioritise Māori and other priority groups, with non-stigmatising, strengths-based approaches. Addressing these data gaps presents a critical opportunity to improve outcomes for children, young people and their whānau.","PeriodicalId":48086,"journal":{"name":"NEW ZEALAND MEDICAL JOURNAL","volume":"137 1606","pages":"92-100"},"PeriodicalIF":1.2,"publicationDate":"2024-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142752016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Online alcohol deliveries: age verification processes of online alcohol delivery companies in Auckland, New Zealand. 在线酒类配送：新西兰奥克兰在线酒类配送公司的年龄验证流程。

IF 1.2

NEW ZEALAND MEDICAL JOURNAL Pub Date : 2024-11-29 DOI: 10.26635/6965.6433

Sarah Sneyd, Molly Richardson

{"title":"Online alcohol deliveries: age verification processes of online alcohol delivery companies in Auckland, New Zealand.","authors":"Sarah Sneyd, Molly Richardson","doi":"10.26635/6965.6433","DOIUrl":"10.26635/6965.6433","url":null,"abstract":"Aim: This study aims to document the age verification processes for online alcohol deliveries in Auckland, New Zealand, with a focus on rapid alcohol delivery (delivery within 2 hours of ordering).Methods: Alcohol orders from Auckland online alcohol delivery companies were placed by a researcher under 25 years of age over a 2-month period in 2023. Procedures were recorded around speed of delivery and age verification processes.Results: In total, 33 (73%) of the 45 online alcohol orders did not require age verification at delivery. This comprises 22 (49% of the total) deliveries left unattended at the door and 11 (24%) in-person deliveries that did not request age verification. The average speed of delivery for rapid alcohol delivery companies was 29.5 minutes and the standard deviation 9.5 minutes.Conclusion: It is common for online alcohol deliveries in Auckland to be left unattended on delivery or delivered without requesting identification. This has implications for increasing alcohol-related harm, including supply to minors. Additional regulation addressing alcohol delivery is needed in New Zealand.","PeriodicalId":48086,"journal":{"name":"NEW ZEALAND MEDICAL JOURNAL","volume":"137 1606","pages":"13-21"},"PeriodicalIF":1.2,"publicationDate":"2024-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142752032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Time for a more evidence-based approach to suicide prevention. 是时候采取更循证的方法来预防自杀了。

IF 1.2

NEW ZEALAND MEDICAL JOURNAL Pub Date : 2024-11-29 DOI: 10.26635/6965.e1606

Sarah Fortune

引用次数: 0

Primary care experience in people with mental health conditions: results from a national patient experience survey. 精神疾病患者的初级保健经验：来自全国患者经验调查的结果。

IF 1.2

NEW ZEALAND MEDICAL JOURNAL Pub Date : 2024-11-29 DOI: 10.26635/6965.6654

Ruth Cunningham, Julie Artus, Fiona Imlach, James Stanley, Tracy Haitana, Helen Lockett, Debbie Peterson, Catherine Gerard

{"title":"Primary care experience in people with mental health conditions: results from a national patient experience survey.","authors":"Ruth Cunningham, Julie Artus, Fiona Imlach, James Stanley, Tracy Haitana, Helen Lockett, Debbie Peterson, Catherine Gerard","doi":"10.26635/6965.6654","DOIUrl":"10.26635/6965.6654","url":null,"abstract":"Aim: The study explored whether the reported experience of primary healthcare differs for survey respondents in Aotearoa New Zealand who self-report having a mental health (MH) condition in comparison with those who do not.Method: Responses to the New Zealand Health Quality & Safety Commission's adult primary care patient experience survey received from August 2020 to May 2022 were analysed. Comparative analysis of patient-reported experience measures were completed to contrast experiences reported by those with and without a MH condition, with results stratified by ethnicity (Māori/non-Māori), age group and gender. Age/gender-standardised estimates for proportions of positive responses to each question were developed for each group alongside standardised risk differences.Results: Our sample comprised 201,650 responses, with 21% reporting a current diagnosed MH condition. While most respondents reported positive experiences of primary healthcare, we found a consistent pattern of fewer positive experiences for those with MH conditions across dimensions of care quality, age and gender groups. When responses were separated by ethnicity, this difference was amplified among Māori.Conclusion: This analysis adds to the increasing body of evidence that experience of MH conditions is associated with worse healthcare experiences. It demonstrates that data are available in Aotearoa New Zealand to routinely monitor and report on primary care experiences for this group. Interventions to improve healthcare should focus on care for Māori with MH conditions as a priority.","PeriodicalId":48086,"journal":{"name":"NEW ZEALAND MEDICAL JOURNAL","volume":"137 1606","pages":"22-39"},"PeriodicalIF":1.2,"publicationDate":"2024-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142752034","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Paediatric palliative care in Aotearoa New Zealand-current state and future direction. 新西兰奥特亚罗瓦的儿科姑息治疗--现状与未来方向。

IF 1.2

NEW ZEALAND MEDICAL JOURNAL Pub Date : 2024-11-08 DOI: 10.26635/6965.6693

Gemma E Aburn, Merryn Gott, Tess Moeke-Maxwell, Ross Drake

引用次数: 0

Access to gluten-free foods for people with coeliac disease in New Zealand. 新西兰乳糜泻患者获得无麸质食品的情况。

IF 1.2

NEW ZEALAND MEDICAL JOURNAL Pub Date : 2024-11-08 DOI: 10.26635/6965.6642

Sophie Hall, Kristin Kenrick, Andrew S Day, Angharad Vernon-Roberts

{"title":"Access to gluten-free foods for people with coeliac disease in New Zealand.","authors":"Sophie Hall, Kristin Kenrick, Andrew S Day, Angharad Vernon-Roberts","doi":"10.26635/6965.6642","DOIUrl":"10.26635/6965.6642","url":null,"abstract":"Aim: A strict gluten-free (GF) diet is the current mainstay of treatment for coeliac disease (CD). A limited range of GF foods are available on prescription for those with CD. GF foods purchased in shops are typically more expensive than gluten-containing equivalents. This study sought to understand how New Zealanders with CD obtain GF products and the changes associated with this.Method: Coeliac New Zealand members were asked to complete an anonymous electronic survey in June 2023.Results: Although 24% of the 522 respondents had accessed GF foods on prescription in the past, only 2% currently used the service. One-third of the respondents were unaware of the service. Cost and limited product range were the key reasons for not accessing prescriptions. Most non-prescription GF foods were purchased from a supermarket, with 54% spending over $50 per week on GF foods. Most respondents (90%) would prefer a discount card to purchase GF products. Preferences regarding the prescription service would be to collect products from a local shop (84%) or a pharmacy (42%).Conclusion: This study indicates a very low uptake of GF products on prescription, with awareness, cost, product range and convenience limiting use of the service. Most respondents would prefer financial support for discounted GF products.","PeriodicalId":48086,"journal":{"name":"NEW ZEALAND MEDICAL JOURNAL","volume":"137 1605","pages":"22-39"},"PeriodicalIF":1.2,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142606963","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Vision loss secondary to cerebral venous sinus thrombosis as the first presenting symptom of a JAK2 positive myeloproliferative neoplasm. 继发于脑静脉窦血栓形成的视力丧失是JAK2阳性骨髓增殖性肿瘤的首发症状。

IF 1.2

NEW ZEALAND MEDICAL JOURNAL Pub Date : 2024-11-08 DOI: 10.26635/6965.6715

Nicholas J Theis, Louis Han, Antony Bedggood

引用次数: 0

Liver transplantation for colorectal liver metastases. 肝移植治疗结直肠肝转移。

IF 1.2

NEW ZEALAND MEDICAL JOURNAL Pub Date : 2024-11-08 DOI: 10.26635/6965.e1605

John McCall

引用次数: 0

Per-oral endoscopic myotomy: a multi-centre New Zealand experience. 口腔内窥镜肌切开术：新西兰多中心经验。

IF 1.2

NEW ZEALAND MEDICAL JOURNAL Pub Date : 2024-11-08 DOI: 10.26635/6965.6609

Christopher Graddon, Rees Cameron, Frank Weilert, Ravinder Ogra, Gary Lim, Imran Khan, Ratna Pandey, Aung Htoo, Georgia Buddle, Alexander Wynne, Cameron Schauer

{"title":"Per-oral endoscopic myotomy: a multi-centre New Zealand experience.","authors":"Christopher Graddon, Rees Cameron, Frank Weilert, Ravinder Ogra, Gary Lim, Imran Khan, Ratna Pandey, Aung Htoo, Georgia Buddle, Alexander Wynne, Cameron Schauer","doi":"10.26635/6965.6609","DOIUrl":"10.26635/6965.6609","url":null,"abstract":"Background and aims: Per-oral endoscopic myotomy (POEM) is an established treatment for achalasia. We aim to review outcomes of all POEM cases performed in New Zealand for achalasia.Methods: A retrospective review of all POEM procedures performed in the five hospitals offering POEM between November 2015 and December 2022 was undertaken. The primary outcome was clinical success, defined as Eckardt score ≤3. Secondary outcomes included procedural complications.Results: One hundred and sixty-six index and four redo POEM procedures were performed by seven clinicians. Ninety-six (58%) were male and mean age was 49.6 years (standard deviation [SD] 19.2 years). Eighty-three (50%) had a previous achalasia intervention. Median length of hospital stay was 1 day (interquartile range [IQR] 1-2 days). Median pre-POEM Eckardt score was 8 (IQR 6-9) and improved to 0 (IQR 0-2) at 6 months (p<0.001). Technical success was achieved in 164 (99%). Clinical success was achieved in 124 (93%) at 6 months and sustained to 12 months in 37/42 (88%) of these patients with follow-up data. Clinical success was achieved in 92% who underwent any prior intervention. There were five reported complications: tunnel leak (three), significant pain (one) and pneumothorax (one). One tunnel leak required thoracotomy for empyema debridement, all other complications were managed conservatively. Forty-seven (31%) reported symptomatic reflux after POEM.Conclusions: This first review of all POEM procedures performed in New Zealand for achalasia demonstrates high 6-month clinical success and safety for the management of achalasia.","PeriodicalId":48086,"journal":{"name":"NEW ZEALAND MEDICAL JOURNAL","volume":"137 1605","pages":"67-76"},"PeriodicalIF":1.2,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142606913","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0